[New therapeutic approaches in type II diabetes].
Reach
G
G
INSERM U 341, Service de Diabétologie, Hôtel-Dieu, Paris.
D000818:Animals; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D005943:Gluconeogenesis / Q000187:drug effects; D005947:Glucose / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D007328:Insulin / Q000378:metabolism; D000078790:Insulin Secretion; D007408:Intestinal Absorption / Q000187:drug effects; D009004:Monosaccharide Transport Proteins / Q000378:metabolism
D007004:Hypoglycemic Agents; D007328:Insulin; D009004:Monosaccharide Transport Proteins; D005947:Glucose
Nouvelles approches thérapeutiques dans le diabète de type II.